PL2529626T3 - Kompozycje i sposoby leczenia lub zapobiegania nowotworowi okrężnicy - Google Patents

Kompozycje i sposoby leczenia lub zapobiegania nowotworowi okrężnicy

Info

Publication number
PL2529626T3
PL2529626T3 PL12182318T PL12182318T PL2529626T3 PL 2529626 T3 PL2529626 T3 PL 2529626T3 PL 12182318 T PL12182318 T PL 12182318T PL 12182318 T PL12182318 T PL 12182318T PL 2529626 T3 PL2529626 T3 PL 2529626T3
Authority
PL
Poland
Prior art keywords
compositions
treating
methods
colon cancer
preventing colon
Prior art date
Application number
PL12182318T
Other languages
English (en)
Inventor
Barry Quart
Original Assignee
Napo Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napo Pharmaceuticals, Inc. filed Critical Napo Pharmaceuticals, Inc.
Publication of PL2529626T3 publication Critical patent/PL2529626T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PL12182318T 2006-05-01 2007-04-30 Kompozycje i sposoby leczenia lub zapobiegania nowotworowi okrężnicy PL2529626T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79707506P 2006-05-01 2006-05-01
EP12182318.1A EP2529626B1 (en) 2006-05-01 2007-04-30 Compositions and methods for treating or preventing colon cancer
EP07761553.2A EP2061327B1 (en) 2006-05-01 2007-04-30 Compositions for treating or preventing inflammatory bowel disease

Publications (1)

Publication Number Publication Date
PL2529626T3 true PL2529626T3 (pl) 2018-04-30

Family

ID=38668466

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12182318T PL2529626T3 (pl) 2006-05-01 2007-04-30 Kompozycje i sposoby leczenia lub zapobiegania nowotworowi okrężnicy

Country Status (9)

Country Link
US (2) US8852649B2 (pl)
EP (2) EP2529626B1 (pl)
AU (1) AU2007248183B2 (pl)
CA (2) CA3025084C (pl)
DK (1) DK2529626T3 (pl)
ES (2) ES2616012T3 (pl)
PL (1) PL2529626T3 (pl)
PT (1) PT2529626T (pl)
WO (1) WO2007130893A2 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
SG195538A1 (en) 2006-05-01 2013-12-30 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
EP2529626B1 (en) 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
US8930989B2 (en) * 2007-08-20 2015-01-06 AdsVantage System and method for providing supervised learning to associate profiles in video audiences
EP2135616B1 (de) 2008-06-19 2016-05-04 Symrise AG Getrocknete Vacciniumfrüchte zur Beeinflussung von Zuständen des Darmes
WO2011024049A2 (en) * 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
US20120202876A1 (en) * 2009-10-06 2012-08-09 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
CN103370101A (zh) 2010-10-31 2013-10-23 萨利克斯药品有限公司 用于治疗hiv相关性腹泻的方法和组合物
US9248120B2 (en) 2011-08-23 2016-02-02 The Board Of Trustees Of The Leland Stanford Junior University Reversing intestinal inflammation by inhibiting retinoic acid metabolism
DE102011085526A1 (de) 2011-10-31 2013-05-02 Wmf Württembergische Metallwarenfabrik Ag Steuerungs-, Regelungs- und Bedienvorrichtung für ein Gargerät
IN2014MN01933A (pl) * 2012-03-13 2015-07-10 Piramal Entpr Ltd
US20170119834A1 (en) * 2014-05-29 2017-05-04 Jaguar Animal Health, Inc. Methods of Treating Diarrhea in Adult Non-Human Animals
DE102014013302A1 (de) * 2014-09-04 2016-03-10 Hochschule Anhalt Wirkstoffzusammensetzung zur Bekämpfung von Pflanzenkrankheiten
MX2017009011A (es) * 2015-01-09 2017-10-02 Jaguar Animal Health Metodos para tratar la diarrea en animales de compañia.
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
CN108853478A (zh) * 2018-07-05 2018-11-23 新疆天健禾牧生物技术有限公司 一种可提高结肠癌和/或直肠癌免疫治疗效果的花青素复合片剂
EP4103283A4 (en) * 2020-03-26 2024-02-28 Provectus Pharmatech, Inc. NEW USES OF HALOGENATED XANTHENES IN ONCOLOGY AND VIROLOGY
CN115887443A (zh) * 2023-02-27 2023-04-04 深圳市第二人民医院(深圳市转化医学研究院) 表没食子儿茶素在制备结直肠癌治疗药物中的应用
CN116650458B (zh) * 2023-07-18 2024-11-19 江苏省中医院 一种巴豆酸钠用于制备治疗溃疡性结肠炎的药物的用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US71793A (en) * 1867-12-03 Georgk h
SE446940B (sv) * 1983-02-16 1986-10-20 Carl Axel Virdalm Medel for bekempande av sjukdomstillstand i matsmeltningsapparaten innehallande skal eller ytterdelar av ber eller frukter
US4498365A (en) 1983-10-14 1985-02-12 Jeff Tripp Apparatus for providing extended versatility in a keyboard-controlled musical instrument in pitch variation, tone alteration characteristics and the like
JPS61205272A (ja) 1985-03-08 1986-09-11 Tsumura Juntendo Inc 新規なタンニン
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
GB8518289D0 (en) 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
EP0214317B1 (fr) * 1985-08-30 1988-08-17 Societe Des Produits Nestle S.A. Produit diététique à activité dépurative et anti-diarrhéique et son procédé de préparation
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
SI9011933A (sl) 1990-10-15 1998-06-30 TANIN SEVNICA Kemična industrija p.o. Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba
US5234922A (en) * 1992-09-28 1993-08-10 University Of Iowa Research Foundation Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea
US5750496A (en) 1996-08-12 1998-05-12 Utah State University Method of controlling cryptosporidium infectons using protease inhibitors
PT935417E (pt) 1996-10-16 2009-07-17 Napo Pharmaceuticals Inc Formulações entéricas de composições poliméricas antidiarreicas de proantocianidina
AU6967198A (en) * 1997-04-10 1998-10-30 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
JP2004529079A (ja) * 2000-12-15 2004-09-24 ファルマシア・コーポレーション 植物抽出物による選択的ｃｏｘ−２阻害
US20040063695A1 (en) * 2002-09-30 2004-04-01 Alan Verkman Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
US7235573B2 (en) * 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
US7208183B2 (en) * 2002-10-05 2007-04-24 Bobrowski Paul J Methods and preparations of the latex from the croton species
CN1543953A (zh) * 2003-11-21 2004-11-10 复旦大学 氟尿嘧啶结肠靶向小丸药物制剂
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
JP2009524585A (ja) 2005-12-15 2009-07-02 バイエル・ヘルスケア・アクチェンゲゼルシャフト ウイルス感染を処置するためのジアリールウレア
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
SG195538A1 (en) * 2006-05-01 2013-12-30 Napo Pharmaceuticals Inc Method for treatment of constipation-predominant irritable bowel syndrome
EP2529626B1 (en) 2006-05-01 2017-11-22 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing colon cancer
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
US20120202876A1 (en) * 2009-10-06 2012-08-09 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
CN103370101A (zh) 2010-10-31 2013-10-23 萨利克斯药品有限公司 用于治疗hiv相关性腹泻的方法和组合物
US20140163096A1 (en) 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea

Also Published As

Publication number Publication date
AU2007248183A1 (en) 2007-11-15
HK1131002A1 (zh) 2010-01-15
DK2529626T3 (en) 2018-01-22
EP2529626B1 (en) 2017-11-22
WO2007130893A2 (en) 2007-11-15
EP2061327A4 (en) 2012-02-15
US20150065566A1 (en) 2015-03-05
CA3025084C (en) 2021-10-12
ES2660551T3 (es) 2018-03-22
EP2529626A1 (en) 2012-12-05
CA3025084A1 (en) 2007-11-15
CA2657803C (en) 2019-01-08
US9987250B2 (en) 2018-06-05
ES2616012T3 (es) 2017-06-09
WO2007130893A3 (en) 2008-01-24
EP2061327B1 (en) 2016-10-05
CA2657803A1 (en) 2007-11-15
US8852649B2 (en) 2014-10-07
US20080031984A1 (en) 2008-02-07
AU2007248183B2 (en) 2013-08-01
PT2529626T (pt) 2018-02-27
EP2061327A2 (en) 2009-05-27

Similar Documents

Publication Publication Date Title
PL2529626T3 (pl) Kompozycje i sposoby leczenia lub zapobiegania nowotworowi okrężnicy
NO20200775A1 (no) Fremgangsmåter og sammensetninger for behandling av kreft
CR10667A (es) Compositions and methods for diagnosing and treating cancer
PL2032166T3 (pl) Kompozycje i sposoby diagnozowania i leczenia nowotworów
IL193014A0 (en) Methods and compositions for treating schizophrenia
PL2155188T3 (pl) Sposoby i kompozycje do leczenia nawrotowego raka
PL3009148T3 (pl) Kompozycje oraz sposoby leczenia i diagnozowania nowotworu
ZA200708575B (en) Methods and compositions for treating or preventing cancer
EP1961065A4 (en) COMPOSITIONS AND METHOD FOR DIAGNOSIS AND TREATMENT OF CANCER
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
ATE526567T1 (de) Zusammensteller und zusammenstellungsverfahren
ZA200900140B (en) Methods and compositions for treating biofilms
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
PL2187967T3 (pl) Sposoby i kompozycje do leczenia raka
BRPI0812932A2 (pt) Composições e métodos de tratar câncer
IL199881A0 (en) Compositions and methods for treating hematopietic malignancies
BRPI0810207A2 (pt) Métodos e composições para o tratamento de câncer
EP2099491A4 (en) COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
EP1855662A4 (en) METHODS AND COMPOSITIONS FOR TREATING CANCER
PL2056799T3 (pl) Kompozycje i sposoby do leczenia lub zapobiegania jaskrze lub jej rozwojowi
NO20073582L (no) Sammensetninger og fremgangsmåter for behandling av schizofreni og beslektede tilstander
EP1959982A4 (en) METHODS AND COMPOSITIONS FOR PREVENTING AND / OR TREATING PANCREATITIS
EP2068629A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
IL196361A0 (en) Combination methods of treating cancer